STOCK COMPARISON
Galenica Sante vs McKesson: Fair Value & Quality
Both stocks run through our valuation models. Here is how Galenica Sante (GALE) and McKesson (MCK) compare, as of Aug 10, 2026.
As of Aug 10, 2026, Fair Value Calculator sees McKesson as the less overvalued of the two: Galenica Sante trades at CHF 82.20 versus a fair value of CHF 61.79 (-25%), while McKesson trades at $870 versus $819 (-6%).
Galenica Sante
GALE.SW · CHF · Health Care
-25%
upside to fair value
overvalued
PriceCHF 82.20
Fair ValueCHF 61.79
Quality60/100
McKesson
MCK · USD · Health Care
-6%
upside to fair value
fairly valued
Price$870
Fair Value$819
Quality66/100
Head-to-head numbers
Green value = the better side for that row (for valuation multiples: lower = cheaper).
Galenica SanteMcKesson
Valuation
23.6×P/E (TTM)21.0×
1.29×P/S (TTM)0.23×
3.60×P/B—
21.8×EV/EBITDA13.9×
—PEG1.57×
2.9%Dividend yield0.4%
CHF 2.50Dividend per share$3.17
Profitability
4%Net margin1%
6%Operating margin2%
12%Return on equity—
4%Return on assets5%
Growth
6%Revenue growth (YoY)6%
1.0%Avg. growth/yr (3Y)13.4%
3.5%Avg. growth/yr (5Y)11.1%
Balance & size
0.41×Debt / equity—
$5BMarket cap$94B
healthyGrowth qualityhealthy
McKesson leads: 3 to 7 metric wins.
Dash = not meaningfully computable, for example with negative equity.
Quality in detail
The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.
Galenica Santeof which business quality 60 · market factors 49
McKessonof which business quality 65 · market factors 63
ProfitabilityMargins and returns on capital today
48
49
Quality GrowthAre margins and returns improving?
31
65
CashflowEarnings quality: real cash, not paper profit
61
47
Fin. StrengthBalance sheet, leverage, solvency risk
69
72
InvestmentDisciplined investing over empire-building
77
76
Low VolatilityCalm price path (market factor)
98
83
MomentumPrice trend over the last 3–12 months (market factor)
35
51
52W MomentumDistance to the 52-week high (market factor)
18
62
Net IssuanceBuybacks instead of dilution
81
100
What the models say
The median fair value (base case) per model family, each in the currency of its trading venue. Green = above the current price, red = below.
Galenica Sante
DCF ModelsCHF 68.32
Earnings-BasedCHF 29.18
Dividend DiscountCHF 31.67
MultiplesCHF 64.03
Asset-BasedCHF 19.93
Growth DCFCHF 62.11
Economic ProfitCHF 30.42
Growth EarningsCHF 64.59
24 of 25 models see the stock below the current price.
McKesson
DCF Models$955
Earnings-Based$444
Dividend Discount$57.26
Multiples$848
Growth DCF$922
Economic Profit$497
Growth Earnings$708
13 of 23 models see the stock below the current price.
Scenario ranges
From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.
Galenica Sante
Bear CHF 46.34Fair Value CHF 61.79Bull CHF 77.24
CHF 82.20 = current price (white tick)
McKesson
Bear $605Fair Value $819Bull $1,034
$870 = current price (white tick)
Compare two other stocks
Tap a field and type again, ticker or company name.
Ranked within their sector
Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.
Galenica Sante · Health Care
Quality score60 · above median
Fair value upside-25% · above median
McKesson · Health Care
Quality score66 · Top 25%
Fair value upside-6% · above median
Bottom line
As of Aug 10, 2026, Fair Value Calculator sees McKesson as the less overvalued of the two: Galenica Sante trades at CHF 82.20 versus a fair value of CHF 61.79 (-25%), while McKesson trades at $870 versus $819 (-6%).
McKesson has the higher quality score (66/100).
See the full analysis →
More comparisons
Popular match-ups from the same sectors, all with fair value and quality score.
Free · Top-25 report
See the undervalued quality stocks every month
Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.
A model-based valuation snapshot from 21 models. Values change with price and fundamentals; the date shown above applies.
